Regulatory

CLINUVEL
Posted by CLINUVEL
April 4, 2022

CLINUVEL appoints new Non-Executive Director

Melbourne, Australia, 04 April 2022 ASX: XETRA-DAX: ADR Level 1: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
March 23, 2022

Change of Director's Interest Notice

Melbourne, Australia, 23 March 2022 ASX: XETRA-DAX: ADR Level 1: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
March 2, 2022

Change of Director's Interest Notice

Melbourne, Australia, 02 March 2022 ASX: XETRA-DAX: ADR Level 1: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
February 23, 2022

CLINUVEL Reports Record December Half Year Operating Profit

Melbourne, Australia, 23 February 2022 ASX: XETRA-DAX: ADR Level 1: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
February 23, 2022

Appendix 4D - ASX Listing Rule 4.2A.3 Half Yearly Report

Melbourne, Australia, 23 February 2022 ASX: XETRA-DAX: ADR Level 1: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
January 19, 2022

Change of Director’s Interest Notice

Melbourne, Australia, 19 January 2022 ASX: XETRA-DAX: Level 1 ADR: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
January 19, 2022

Notification of Cessation of Securities

Melbourne, Australia, 19 January 2022 ASX: XETRA-DAX: Level 1 ADR: CUV UR9...

Read More
Lachlan Hay
Posted by Lachlan Hay
November 8, 2021

CLINUVEL Expands Pharmaceutical Portfolio

Melanocortin drug NEURACTHEL® (ACTH) added for neurological, endocrinological and degenerative disorders

Read More
CLINUVEL
Posted by CLINUVEL
November 8, 2021

CLINUVEL Adds ACTH to Portfolio

Melbourne, Australia, 08 November 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
October 8, 2021

Appendix 4G & Corporate Governance Statement

Melbourne, Australia, 08 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
October 8, 2021

CLINUVEL PHARMACEUTICALS LTD 2021 Annual General Meeting - Notice of Meeting & Explanatory Memorandum

Melbourne, Australia, 08 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
September 16, 2021

Notification regarding unquoted securities - CUV

Melbourne, Australia, 16 September 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
August 27, 2021

CLINUVEL Investor Webinar Financial Results Year Ended 30 June 2021

Melbourne, Australia, 27 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
August 26, 2021

Corporate Presentation - FY2021 Results

Melbourne, Australia, 26 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
August 26, 2021

Appendix 4E and Preliminary Financial Report

Melbourne, Australia, 26 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More